Procter & Gamble shares weekly forecast: sellers maintain pressure as MACD signals persist

Procter & Gamble shares weekly forecast: sellers maintain pressure as MACD signals persist
Procter & Gamble rises 0.55% this week

Shares of The Procter & Gamble Company (PG) are trading near $145 as selling pressure has pushed the stock into oversold territory. Despite modest movement this week, technical signals remain cautious heading into the next stretch as downside risk persists.

PG price prediction
24H 0.01%
$163.66
48H 0.4%
$164.3
7D 0.68%
$164.75
1M 10%
$180
3M 5.32%
$172.34
6M 7.05%
$175.17
12M 6.98%
$175.07
Current price: $163.64 2.10 1.30%
Closed 11/02
Daily range 162.49 Arrow from to Icon 164.36
Weekly range 158.12 Arrow from to Icon 163.57
Loading...

Highlights

  • Shares of Procter & Gamble edged higher to $145.48 but remain below key moving averages, signaling a bearish long-term trend.
  • Technical indicators show prevailing selling pressure despite the Stochastic RSI nearing oversold conditions, suggesting limited bullish support in the near term.
  • Shares are expected to trade within $142.39 to $148.56 this week, with a high likelihood of continued consolidation between $140.2 support and $147.01 resistance.

Earnings beat offsets revenue miss amid rising cost headwinds

Procter & Gamble reported fiscal fourth-quarter and full-year 2026 results, with adjusted earnings per share of $1.43 beating expectations but revenue of $21.2 billion missing consensus, according to CNBC. The company is facing significant cost headwinds of approximately $1 billion after-tax in fiscal 2027 due to higher raw materials, energy, and transportation costs. During the quarter, PG returned over $15 billion to shareholders through dividends and share buybacks, and announced the retirement of Jon Moeller, with Shailesh Jejurikar set to succeed him.

Procter & Gamble Company asset chart
Procter & Gamble Company price dynamics. Source: TradingView.

Selling momentum builds as weekly volatility and support converge

On the daily chart, Procter & Gamble displays a flat trend with a contained move within a narrow range, while volatility over the past week measured 4.92%. MACD and the Awesome Oscillator both point to selling pressure, with MACD signaling “Sell” and AO also in a sell direction. In contrast, Stochastic RSI is oversold at 18.35, introducing a note of potential support, though this bullish cue is countered by downward momentum. The nearest support sits at $140.2, while resistance is close at $147.01, defined by the Ichimoku Kijun.

Downside bias dominates as low breakout risk guides next week

Over the coming trading week, shares are expected to move within a range of $142.39 to $148.56. There is a very low probability of an increase and a very high probability of a decrease. The base case is continued consolidation between $140.2 and $147.01. A break above resistance at $147.01 could see a move toward the upper range, while failure of support at $140.2 opens up further downside risk.

Viktoras Karapetjanc, expert at Traders Union, sees a week of consolidation for Procter & Gamble after it moved into oversold territory near $145. The company’s strong earnings per share and robust shareholder returns offer long-term positives, even as cost pressures and leadership changes introduce uncertainty. Technically, key indicators still show downside risk, but the support at $140.2 may attract buyers looking for value. Karapetjanc believes macro and fundamental strength remain, with technical signals pointing to continued range-bound action. "Given the combination of resilient fundamentals and oversold technicals, I see opportunity for patient buyers as long as support holds this week."

Previously it was reported that Procter & Gamble shares were consolidating within a narrow range, with technical signals warning of potential downside risk. Recent results and sustained selling pressure confirm the bearish technical setup, making support at $140.2 a critical level to watch for further direction.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.